Bacitracin Zinc And Polymyxin B Sulfate Ointment
NDC Package 68071-5267-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Bacitracin Zinc And Polymyxin B Sulfate ointment is a medication contraindicated in those individuals who have shown hypersensitivity to any of its components. This formulation utilizes a ointment delivery system. Marketed by Nucare Pharmaceuticals,inc., this product is identified by NDC 68071-5267 and is authorized under FDA application ANDA064046.

Identification & Billing

NDC Package Code
68071-5267-3
Package Description
3.5 g in 1 BOX
Product Code
68071-5267
11-Digit Billing Format
68071526703
RxNorm Crosswalk
  • RxCUI: 308511 - bacitracin zinc 500 UNT / polymyxin B sulfate 10,000 UNT per GM Ophthalmic Ointment
  • RxCUI: 308511 - bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment
  • RxCUI: 308511 - bacitracin (as bacitracin zinc) 500 UNT / polymyxin B (as polymyxin B sulfate) 10,000 UNT per GM Ophthalmic Ointment

Clinical Specifications

Proprietary Name
Bacitracin Zinc And Polymyxin B Sulfate
Non-Proprietary Name
Bacitracin Zinc And Polymyxin B Sulfate
Substance Name
Bacitracin Zinc; Polymyxin B Sulfate
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
Pharmacologic Class
Usage Information
This product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

Regulatory & Marketing

Labeler Name
Nucare Pharmaceuticals,inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA064046
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-25-2008
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68071-5267-3 identifies a specific commercial package of 3.5 g in 1 box of Bacitracin Zinc And Polymyxin B Sulfate, a human prescription drug labeled by Nucare Pharmaceuticals,inc.. This ointment is formulated for ophthalmic use and contains bacitracin zinc; polymyxin b sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nucare Pharmaceuticals,inc. on April 25, 2008. The current certification is valid through December 31, 2026.

How is this Nucare Pharmaceuticals,inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68071526703. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68071-5267-3
11-Digit CMS (5-4-2)
68071-5267-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.